Atherosclerotic cardiovascular disease is one of the major leading global causes of death.
Growing evidence has demonstrated that gut microbiota (GM) and its metabolites play a …

Gut microbiota and its metabolites such as short chain fatty acids (SCFA),
lipopolysaccharides (LPS), and trimethylamine-N-oxide (TMAO) impact cardiovascular …

Atherosclerosis is a leading cause of cardiovascular disease and mortality worldwide.
Alterations in the gut microbiota composition, known as gut dysbiosis, have been shown to …

Atherosclerosis remains the leading cause of death worldwide. Lifestyle modification,
including diet and exercise, is recommended to be the primary prevention strategy for …

Infections have been linked to the development of cardiovascular disease and
atherosclerosis. Findings from the past decade have identified microbial ecosystems …

Emerging data have demonstrated a strong association between the gut microbiota and the
development of cardiovascular disease (CVD) risk factors such as atherosclerosis …

Hypercholesterolemia plays a causal role in the development of atherosclerosis and is one
of the main risk factors for cardiovascular disease (CVD), the leading cause of death …

Gut microbiota remains a very interesting, yet largely unexplored ecosystem inside the
human organism. The importance of this ecosystem for the physiology and the …

Introduction: Cardiometabolic diseases (CMD) are a group of interrelated disorders such as
metabolic syndrome, type 2 diabetes mellitus and cardiovascular diseases (CVD). As the …

Abstract Purpose of Review Studies in microbiota-mediated health risks have gained
traction in recent years since the compilation of the Human Microbiome Project. No longer …